SLC2A1 and colonic neoplasm: In colon cancer, SMAD4 deficiency results in increased MMP9 expression in colon cancer cells, amplifying the expression of the hypoxia-inducible factor GLUT1, thereby promoting aerobic glycolysis processes [38].